BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha

BetterLife Pharma disclosed that its own independent director, Dr. Steven Sangha, filed a Notice of Civil Claim against the company in the Supreme Court of British Columbia on October 8, 2026. The dispute concerns repayment of the principal of a convertible debenture issued to Dr. Sangha in June 2026; the plaintiff seeks an order forcing conversion into 33,333,333 common shares and 33,333,333 share purchase warrants.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.